輸入代號或公司名稱後按 Enter
4735

豪展

+0.05 (+0.14%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
35.658成交張數6.39本益比1.21股價淨值比5.62%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025936年增 +1.0%
毛利率202531.6%最新一期
營業利益率20255.0%最新一期
每股盈餘20252.46年增 +51.9%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計74.0%73.6%74.9%68.7%63.8%71.0%70.3%69.9%72.5%68.4%
營業毛利(毛損)26.0%26.4%25.1%31.3%36.2%29.0%29.7%30.1%27.5%31.6%
營業毛利(毛損)淨額26.0%26.4%25.1%31.3%36.2%29.0%29.7%30.1%27.5%31.6%
推銷費用3.3%3.4%3.0%3.2%2.4%1.9%2.4%3.8%3.1%3.0%
管理費用8.6%9.1%8.8%9.9%6.0%7.3%11.5%14.7%14.5%13.7%
研究發展費用3.1%3.6%3.5%4.1%2.3%3.0%6.1%10.0%8.2%9.9%
營業費用合計15.0%16.2%15.3%17.2%10.6%12.2%20.0%28.4%25.8%26.6%
營業利益(損失)11.0%10.2%9.8%14.2%25.6%16.8%9.7%1.7%1.7%5.0%
利息收入0.0%0.0%0.2%1.2%0.8%0.2%
其他收入0.3%0.6%0.3%0.2%0.5%0.2%1.6%1.1%0.6%2.0%
其他利益及損失淨額-2.3%0.4%-0.4%-0.4%-1.0%0.0%0.0%1.1%3.2%2.8%
財務成本淨額0.1%0.2%0.4%0.5%0.1%0.2%0.1%0.3%0.4%0.0%
營業外收入及支出合計-2.2%0.5%-0.5%-0.7%-0.6%0.0%1.7%3.0%4.2%5.1%
稅前淨利(淨損)8.8%10.7%9.3%13.5%25.0%16.8%11.4%4.7%5.9%10.0%
所得稅費用(利益)合計1.2%1.6%1.9%3.0%5.0%3.3%2.9%-0.1%-0.3%0.1%
繼續營業單位本期淨利(淨損)7.6%9.1%7.4%10.5%20.0%13.6%8.4%4.9%6.2%10.0%
本期淨利(淨損)7.6%9.1%7.4%10.5%20.0%13.6%8.4%4.9%6.2%10.0%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-1.0%2.4%-0.2%0.3%-5.1%-0.2%-3.8%5.0%
不重分類至損益之項目:2.4%-0.2%0.3%-5.1%-0.2%-3.8%5.0%
國外營運機構財務報表換算之兌換差額-0.3%-0.7%0.1%-0.4%-0.2%0.0%1.0%-0.4%2.9%0.4%
後續可能重分類至損益之項目:-0.4%-0.2%0.0%1.0%-0.4%2.9%0.4%
其他綜合損益(淨額)0.0%-2.5%-0.9%2.0%-0.4%0.3%-4.1%-0.6%-0.8%5.3%
本期綜合損益總額7.6%6.6%6.6%12.5%19.6%13.9%4.3%4.3%5.4%15.3%
母公司業主(淨利∕損)7.6%9.1%7.4%10.5%20.0%13.6%8.4%4.9%6.2%10.0%
母公司業主(綜合損益)7.6%6.6%6.6%12.5%19.6%13.9%4.3%4.3%5.4%15.3%
基本每股盈餘0.2%0.3%0.2%0.3%0.6%0.4%0.2%0.1%0.2%0.3%
稀釋每股盈餘0.2%0.3%0.2%0.3%0.6%0.4%0.2%0.1%0.2%0.3%
預期信用減損損失(利益)0.0%0.0%0.0%-0.0%-0.0%0.0%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%
採用權益法認列之關聯企業及合資損益之份額淨額-0.0%-0.2%0.0%
備供出售金融資產未實現評價損益0.3%-1.8%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。